Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

NCT05402020 · clinicaltrials.gov ↗

COMPLETED

Status

17018

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium (Tio)
DRUG: Inhaled corticosteroids (ICS)
DRUG: Olodaterol (Olo)
DRUG: Long-acting β2-agonists (LABA)

Sponsor

Boehringer Ingelheim